Segall Bryant & Hamill LLC Sells 463,071 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Segall Bryant & Hamill LLC cut its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 37.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 781,879 shares of the company's stock after selling 463,071 shares during the period. Segall Bryant & Hamill LLC owned approximately 0.91% of Pediatrix Medical Group worth $10,258,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Quest Partners LLC raised its stake in Pediatrix Medical Group by 25.6% during the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company's stock valued at $35,000 after buying an additional 622 shares during the last quarter. Parkside Financial Bank & Trust grew its holdings in shares of Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after acquiring an additional 1,040 shares during the period. Quarry LP increased its position in Pediatrix Medical Group by 54.1% during the third quarter. Quarry LP now owns 4,735 shares of the company's stock valued at $55,000 after acquiring an additional 1,662 shares during the last quarter. AlphaQuest LLC lifted its holdings in Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after acquiring an additional 2,012 shares during the period. Finally, Smartleaf Asset Management LLC boosted its position in Pediatrix Medical Group by 750.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock worth $91,000 after purchasing an additional 6,090 shares during the last quarter. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Price Performance

Shares of MD stock traded up $0.37 on Monday, hitting $14.53. 857,693 shares of the stock traded hands, compared to its average volume of 838,170. The firm has a market cap of $1.25 billion, a price-to-earnings ratio of -12.11, a PEG ratio of 1.74 and a beta of 1.49. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The firm has a 50 day simple moving average of $14.41 and a two-hundred day simple moving average of $13.72. Pediatrix Medical Group, Inc. has a 52 week low of $6.62 and a 52 week high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The firm had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million. As a group, equities research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. StockNews.com upgraded shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research note on Wednesday, January 22nd. Macquarie started coverage on shares of Pediatrix Medical Group in a research report on Monday, December 16th. They issued an "outperform" rating and a $18.00 price target on the stock. Truist Financial boosted their price objective on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a "hold" rating in a research report on Friday, February 21st. Finally, UBS Group raised their target price on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a "neutral" rating in a report on Friday, February 21st. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $17.08.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.